Explore All Access
Check if your research matches the topics covered in OncoTargets and Therapy?
- Degree of match
- Common matching concepts
- Additional journal recommendations
OncoTargets and Therapy : Impact Factor & More
eISSN: 1178-6930pISSN: 1178-6930
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
OncoTargets and Therapy is a peer-reviewed medical journal covering research on all aspects of oncology. The journal was established in 2008 and is published by Dove Medical Press.
OncoTargets and Therapy Key Metrics
CiteScore 
7
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.81
Time to Accept
3
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months29%
4 to 6 months65%
7 to 9 months6%
Above 9 months0%
Did you find this useful?
Topics Covered on OncoTargets and Therapy
Cancer
Western blot
Overall survival
Lung cancer
Assay
Progression-free survival
Central nervous system
Hepatocellular carcinoma
Irradiation
Toxicity
Reactive oxygen species
Cell cycle
Immunotherapy
Chordoma
Epidermal growth factor receptor
Crizotinib
Lung
Colorectal cancer
Chemotherapy
Osteosarcoma
OncoTargets and Therapy Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2410 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2008 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in OncoTargets and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in OncoTargets and Therapy
Ubiquitination-Binding Enzyme 2C is Associated with Cancer Development and Prognosis and is a Potential Therapeutic Target
- 1 Dec 2024
- OncoTargets and Therapy
Long Non Coding RNA SNHG16 Facilitates Proliferation, Migration, Invasion and Autophagy of Neuroblastoma Cells via Sponging miR-542-3p and Upregulating ATG5 Expression [Retraction
- 1 Dec 2024
- OncoTargets and Therapy
Screening and Studying of Blood miRNAs as Potential Diagnostic Markers for Papillary Thyroid Carcinoma
- 1 Dec 2024
- OncoTargets and Therapy
Analysis of Lymphovascular Infiltration and Tumor-Associated Macrophages in Cervical Cancer Immunoescape.
- 1 Nov 2024
- OncoTargets and therapy
The Application of Prostate Specific Membrane Antigen in the Diagnosis and Treatment of Prostate Cancer: Status and Challenge.
- 1 Nov 2024
- OncoTargets and therapy
Identification of Potential Biomarkers in Papillary Thyroid Carcinoma Based on Proteomics.
- 1 Nov 2024
- OncoTargets and therapy
Ubiquitination-Binding Enzyme 2C is Associated with Cancer Development and Prognosis and is a Potential Therapeutic Target
- 1 Dec 2024
- OncoTargets and Therapy
Long Non Coding RNA SNHG16 Facilitates Proliferation, Migration, Invasion and Autophagy of Neuroblastoma Cells via Sponging miR-542-3p and Upregulating ATG5 Expression [Retraction
- 1 Dec 2024
- OncoTargets and Therapy
Screening and Studying of Blood miRNAs as Potential Diagnostic Markers for Papillary Thyroid Carcinoma
- 1 Dec 2024
- OncoTargets and Therapy
Analysis of Lymphovascular Infiltration and Tumor-Associated Macrophages in Cervical Cancer Immunoescape.
- 1 Nov 2024
- OncoTargets and therapy
The Application of Prostate Specific Membrane Antigen in the Diagnosis and Treatment of Prostate Cancer: Status and Challenge.
- 1 Nov 2024
- OncoTargets and therapy
Identification of Potential Biomarkers in Papillary Thyroid Carcinoma Based on Proteomics.
- 1 Nov 2024
- OncoTargets and therapy
Compare Similar Journals with OncoTargets and Therapy
Select Journals to Compare with OncoTargets and Therapy
Total journals - 10
You can select up to 3 Journals at a time
Oncology Letters
Publisher: SPANDIDOS PUBL LTD
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancer Management and Research
Publisher: DOVE MEDICAL PRESS LTD
Oncotarget
Publisher: Impact Journals
Cancer Cell International
Publisher: BMC
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
BMC Cancer
Publisher: BMC
Journal of Cancer
Publisher: IVYSPRING INT PUBL
Cancers
Publisher: MDPI
Oncology Reports
Publisher: SPANDIDOS PUBL LTD
0 Journals Selected to compare with
OncoTargets and Therapy
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on OncoTargets and Therapy
How long has OncoTargets and Therapy been actively publishing? 
OncoTargets and Therapy has been in operation since 2008 till date.
What is the publishing frequency of OncoTargets and Therapy?
OncoTargets and Therapy published with a Continuous publication frequency.
How many articles did OncoTargets and Therapy publish last year?
In 2023, OncoTargets and Therapy publsihed 147 articles.
What is the eISSN & pISSN for OncoTargets and Therapy?
For OncoTargets and Therapy, eISSN is 1178-6930 and pISSN is 1178-6930.
What is Citescore for OncoTargets and Therapy?
Citescore for OncoTargets and Therapy is 7.
What is SNIP score for OncoTargets and Therapy?
SNIP score for OncoTargets and Therapy is 0.81.
What is the SJR for OncoTargets and Therapy?
SJR for OncoTargets and Therapy is Q2.
Who is the publisher of OncoTargets and Therapy?
DOVE MEDICAL PRESS LTD is the publisher of OncoTargets and Therapy.
